These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20936626)

  • 21. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets.
    Siddiqui O; Hung HM; O'Neill R
    J Biopharm Stat; 2009; 19(2):227-46. PubMed ID: 19212876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new method for the comparison of survival distributions.
    Lin X; Xu Q
    Pharm Stat; 2010; 9(1):67-76. PubMed ID: 19306313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined test procedures in the meta-analysis of controlled clinical trials.
    Knapp G; Hartung J
    Stud Health Technol Inform; 2000; 77():34-8. PubMed ID: 11187570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal and repeated cross-sectional cluster-randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods.
    Localio AR; Berlin JA; Have TR
    Stat Med; 2006 Aug; 25(16):2720-36. PubMed ID: 16345043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Monte Carlo approach for change-point detection in the Cox proportional hazards model.
    Liu M; Lu W; Shao Y
    Stat Med; 2008 Aug; 27(19):3894-909. PubMed ID: 18254131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Likelihood inference on the relative risk in split-cluster designs.
    Shoukri MM; Colak D; Donner A
    Clin Trials; 2011 Feb; 8(1):37-47. PubMed ID: 21335588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mixture model with random-effects components for clustering correlated gene-expression profiles.
    Ng SK; McLachlan GJ; Wang K; Ben-Tovim Jones L; Ng SW
    Bioinformatics; 2006 Jul; 22(14):1745-52. PubMed ID: 16675467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting and adjusting for small-study effects in meta-analysis.
    Rücker G; Carpenter JR; Schwarzer G
    Biom J; 2011 Mar; 53(2):351-68. PubMed ID: 21374698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detecting latent taxa: Monte Carlo comparison of taxometric, mixture model, and clustering procedures.
    Cleland CM; Rothschild L; Haslam N
    Psychol Rep; 2000 Aug; 87(1):37-47. PubMed ID: 11026388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II cancer clinical trials with a one-sample log-rank test and its corrections based on the Edgeworth expansion.
    Sun X; Peng P; Tu D
    Contemp Clin Trials; 2011 Jan; 32(1):108-13. PubMed ID: 20888929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varying cluster sizes in trials with clusters in one treatment arm: sample size adjustments when testing treatment effects with linear mixed models.
    Candel MJ; Van Breukelen GJ
    Stat Med; 2009 Aug; 28(18):2307-24. PubMed ID: 19472169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prescription fraud detection model.
    Aral KD; Güvenir HA; Sabuncuoğlu I; Akar AR
    Comput Methods Programs Biomed; 2012 Apr; 106(1):37-46. PubMed ID: 22088866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating mixture modeling for clustering: recommendations and cautions.
    Steinley D; Brusco MJ
    Psychol Methods; 2011 Mar; 16(1):63-79. PubMed ID: 21319900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analyzing excessive no changes in clinical trials with clustered data.
    Lu SE; Lin Y; Shih WC
    Biometrics; 2004 Mar; 60(1):257-67. PubMed ID: 15032797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simulation study to assess statistical methods for binary repeated measures data.
    Masaoud E; Stryhn H
    Prev Vet Med; 2010 Feb; 93(2-3):81-97. PubMed ID: 20004989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An extended power of cluster detection tests.
    Takahashi K; Tango T
    Stat Med; 2006 Mar; 25(5):841-52. PubMed ID: 16453379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sample size for two-stage studies with maintenance therapy.
    Feng W; Wahed AS
    Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporating correlation for multivariate failure time data when cluster size is large.
    Xue L; Wang L; Qu A
    Biometrics; 2010 Jun; 66(2):393-404. PubMed ID: 19673860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of gatekeeping and other testing methods for identifying superior drug combinations in bifactorial designs with isotonic parameters.
    Soulakova JN
    J Biopharm Stat; 2011 Jul; 21(4):635-49. PubMed ID: 21516561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.